Rituximab
Indication
Autoimmune haemolytic anaemia
Red
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Immune system and Malignant Disease
Background
Rituximab is recommended as an alternative treatment for adults with AIHA where patients are contraindicated to or fail to respond to standard active treatments (e.g. corticosteroids).
Treatment requires initiation and continuation by specialist haematology services.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: